Dr. Jeckyll and Marina Hyde
16 May 2024
Fanatics Call for Climate ‘Deniers’ to Be Jailed
16 May 2024
With a vaccine as hurried out as this one, it is almost inevitable that rare side effects are going to show up when we vaccinate millions that wouldn't have shown up in the trials when we vaccinated thousands.
The leaders of Italy and France have made it clear that they will "quickly resume" their countries' rollouts of the Oxford-AstraZeneca Covid vaccine when the European Medicines Agency gives the green light on Thursday.
The EU's medicines agency has responded to concerns over the Oxford-AstraZeneca Covid vaccine, saying there is "no indication" that the vaccine is the cause of reported blood clots.
All remaining over-50s are expected to be called up for a Covid vaccine in the coming days with a surge in supply meaning half of all UK adults will have had their first jab by the end of the week.
Germany and France are the latest countries to pause their rollouts of the AstraZeneca jab because of fears over blood clotting. Boris Johnson, Britain's medicines regulator and AZ itself have all defended the vaccine.
Ireland and the Netherlands have joined the list of countries that have suspended the use of AstraZeneca's Covid vaccine because of fears over blood clotting.
Half of bosses won't let their staff return to offices if they refuse to take the Covid vaccine, according to a new survey of 300 business owners.
Concerns about the Oxford-AstraZeneca Covid vaccine have intensified following reports of three Norwegian health workers suffering from blood clots after receiving the jab.
PHE found a 48% increase in infection risk among over 80s in the week after the first jab. The FDA found 40%. Now a study from Denmark finds 40%. Will the Government publish the data to set our minds at ease?
Denmark has temporarily halted the administration of the AstraZeneca Covid vaccine following reports of cases of blood clots forming. Austria has also paused usage while investigating a death from coagulation disorders.
© Skeptics Ltd.